In recent years, the rapid proliferation of genomic tests for use in clinical practice has prompted healthcare systems to use a health technology assessment (HTA) approach to distinguish valuable from unwarranted applications. In this study, we narratively review the Italian HTA mechanisms for medical devices (MDs), both at the national and regional levels, and discuss the opportunity and benefits of extending them to genomic technologies, for which a dedicated assessment path was advocated by the National Plan for Public Health Genomics in 2017. We found that the National Health Technology Assessment Program for MDs, completed in 2019, had developed a structured pathway for the HTA of MDs; it established a hub-and-spoke structure, run by a governmental institution, and put in place transparent methodological procedures to cover all four HTA phases (i.e., proposal and prioritization, assessment, appraisal, and dissemination). However, several factors have hindered its adoption, and the regions are at different stages of its implementation. For these reasons, efforts should be made to ensure its effective deployment, both at national and regional levels. In addition, we argue that to harmonize the institutional roles and methodological procedures adopted, the time has come to concentrate resources on a single pathway for the assessment of all technologies that include both MDs and genomic applications.

Managing the introduction of genomic applications into the National Health Service. A special challenge for health technology assessment in Italy / Pitini, E.; Migliara, G.; Baccolini, V.; Isonne, C.; Mazzalai, E.; Turatto, F.; Salerno, C.; Pagano, F.; Menzano, M. T.; De Vito, C.; Marzuillo, C.; Villari, P.. - In: FRONTIERS IN PUBLIC HEALTH. - ISSN 2296-2565. - 10:(2022), pp. 1-9. [10.3389/fpubh.2022.932093]

Managing the introduction of genomic applications into the National Health Service. A special challenge for health technology assessment in Italy

Pitini E.
;
Migliara G.;Baccolini V.;Isonne C.;Mazzalai E.;Turatto F.;Salerno C.;Pagano F.;De Vito C.;Marzuillo C.;Villari P.
2022

Abstract

In recent years, the rapid proliferation of genomic tests for use in clinical practice has prompted healthcare systems to use a health technology assessment (HTA) approach to distinguish valuable from unwarranted applications. In this study, we narratively review the Italian HTA mechanisms for medical devices (MDs), both at the national and regional levels, and discuss the opportunity and benefits of extending them to genomic technologies, for which a dedicated assessment path was advocated by the National Plan for Public Health Genomics in 2017. We found that the National Health Technology Assessment Program for MDs, completed in 2019, had developed a structured pathway for the HTA of MDs; it established a hub-and-spoke structure, run by a governmental institution, and put in place transparent methodological procedures to cover all four HTA phases (i.e., proposal and prioritization, assessment, appraisal, and dissemination). However, several factors have hindered its adoption, and the regions are at different stages of its implementation. For these reasons, efforts should be made to ensure its effective deployment, both at national and regional levels. In addition, we argue that to harmonize the institutional roles and methodological procedures adopted, the time has come to concentrate resources on a single pathway for the assessment of all technologies that include both MDs and genomic applications.
2022
health technology assessment (hta); national health service; public health genomics; public health governance; italy; narrative review; genomic test
01 Pubblicazione su rivista::01g Articolo di rassegna (Review)
Managing the introduction of genomic applications into the National Health Service. A special challenge for health technology assessment in Italy / Pitini, E.; Migliara, G.; Baccolini, V.; Isonne, C.; Mazzalai, E.; Turatto, F.; Salerno, C.; Pagano, F.; Menzano, M. T.; De Vito, C.; Marzuillo, C.; Villari, P.. - In: FRONTIERS IN PUBLIC HEALTH. - ISSN 2296-2565. - 10:(2022), pp. 1-9. [10.3389/fpubh.2022.932093]
File allegati a questo prodotto
File Dimensione Formato  
Pitini_Managing_2022.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 561.53 kB
Formato Adobe PDF
561.53 kB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1652824
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 1
social impact